Articles Tagged With:
-
Patients Share Preferences About Data Privacy
Most want security and accountability, are concerned about who can access their information and for what purposes.
-
TJC Urges Caution About Cognitive Biases in Diagnostics
So-called “diagnostic overshadowing” can lead clinicians to miss the real causes of health problems.
-
COVID-19 and Headache
Headache is a common feature of acute COVID-19 infection, as well as a long-standing feature of “long COVID” after recovery from the acute infection. Treatment is symptomatic, based on the characteristics of the headache syndrome.
-
Myopathy Is Associated with Post-COVID-19 Fatigue
Prolonged fatigue after COVID-19 infection may be associated with evidence of myopathy, based on physical examination, electromyography, and muscle biopsy.
-
Risk Factors Associated with Alzheimer’s Disease and Related Dementias in the United States
Two independent analyses of U.S. national surveys support evidence that targeted risk-reduction strategies may reduce the burden of Alzheimer’s disease in the population.
-
Noradrenergic Drugs for the Symptomatic Treatment of Alzheimer’s Disease
This meta-analysis provides evidence that drugs modulating the noradrenergic system could be effective in treating cognitive symptoms and apathy in patients with Alzheimer’s disease.
-
Diabetic Emergencies: Part II
This issue concludes our two-part discussion of diabetic emergencies. Part I covered pathophysiology and clinical presentation, and part II will cover diagnostic evaluation and management.
-
Too Much Phthalate Exposure Could Induce Preterm Labor
Common chemical could lead to births occurring three weeks or more early.
-
COVID-19 Exacerbated Antimicrobial Resistance
CDC report indicates related infections and deaths rose 15% in hospitals in 2020.
-
Two-Dose Novavax Added to List of U.S. COVID-19 Vaccines
The FDA issued an emergency use authorization for the fourth vaccine.